dehydroepiandrosterone sulfate has been researched along with Androgen-Independent Prostatic Cancer in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Armstrong, CM; D'Abronzo, LS; Evans, CP; Gao, AC; Li, PK; Liu, C; Liu, L; Lombard, AP; Lou, W; Ning, S; Yang, JC; Zhao, J; Zhao, R | 1 |
| Ikeda, K; Inoue, S; Migita, T; Obinata, D; Soga, T; Takahashi, S; Takayama, KI; Urano, T | 1 |
| Penning, TM | 1 |
| Fujisawa, M; Furukawa, J; Harada, K; Hinata, N; Nakano, Y; Sakamoto, M; Suzuki, K; Terakawa, T | 1 |
| Alsinnawi, M; Balk, S; Bianchi-Frias, D; Burns, J; Cho, E; Montgomery, RB; Mostaghel, EA; Nelson, PS; Porter, C; Slee, AE; Sowalsky, A; Taplin, ME; True, L; Ye, H; Zhang, A; Zhang, X | 1 |
| Balk, SP; Kantoff, PW; Montgomery, B; Mostaghel, E; Nelson, PS; Penning, TM; Tamae, D; Taplin, ME | 1 |
| Agus, DB; Bargfrede, M; Carthon, B; Clark, WR; Gandhi, JG; Heath, E; Kong, N; Lin, J; Liu, G; Moran, S; Oh, WK; Petrylak, DP; Suri, A | 1 |
2 review(s) available for dehydroepiandrosterone sulfate and Androgen-Independent Prostatic Cancer
| Article | Year |
|---|---|
Dehydroepiandrosterone (DHEA)-SO
Topics: Antineoplastic Agents; Dehydroepiandrosterone Sulfate; Delayed-Action Preparations; Gene Expression Regulation, Neoplastic; Humans; Male; Prostatic Neoplasms, Castration-Resistant; Steroid 17-alpha-Hydroxylase | 2018 |
The DHEA-sulfate depot following P450c17 inhibition supports the case for AKR1C3 inhibition in high risk localized and advanced castration resistant prostate cancer.
Topics: 3-Hydroxysteroid Dehydrogenases; Aldo-Keto Reductase Family 1 Member C3; Dehydroepiandrosterone Sulfate; Humans; Hydroxyprostaglandin Dehydrogenases; Male; Prostatic Neoplasms, Castration-Resistant; Risk; Steroid 17-alpha-Hydroxylase | 2015 |
1 trial(s) available for dehydroepiandrosterone sulfate and Androgen-Independent Prostatic Cancer
| Article | Year |
|---|---|
Phase 1/2 study of orteronel (TAK-700), an investigational 17,20-lyase inhibitor, with docetaxel-prednisone in metastatic castration-resistant prostate cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Dehydroepiandrosterone Sulfate; Disease Progression; Disease-Free Survival; Docetaxel; Dose-Response Relationship, Drug; Humans; Imidazoles; Male; Middle Aged; Naphthalenes; Prednisone; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Steroid 17-alpha-Hydroxylase; Taxoids; Testosterone | 2015 |
4 other study(ies) available for dehydroepiandrosterone sulfate and Androgen-Independent Prostatic Cancer
| Article | Year |
|---|---|
Steroid Sulfatase Stimulates Intracrine Androgen Synthesis and is a Therapeutic Target for Advanced Prostate Cancer.
Topics: Androgen Antagonists; Androgens; Androstenes; Benzamides; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Male; Neoplasm Staging; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; RNA-Seq; Steryl-Sulfatase | 2020 |
ACSL3 promotes intratumoral steroidogenesis in prostate cancer cells.
Topics: 3-Hydroxysteroid Dehydrogenases; Aldo-Keto Reductase Family 1 Member C3; Cell Line, Tumor; Cell Proliferation; Coenzyme A Ligases; Dehydroepiandrosterone Sulfate; Gene Expression Regulation, Neoplastic; Glucuronosyltransferase; Humans; Hydroxyprostaglandin Dehydrogenases; Lipogenesis; Male; Prostatic Neoplasms, Castration-Resistant; Testosterone | 2017 |
Serum DHEA-S Is a Predictive Parameter of Abiraterone Acetate in Patients with Castration-resistant Prostate Cancer.
Topics: Abiraterone Acetate; Aged; Aged, 80 and over; Antineoplastic Agents; Biomarkers, Tumor; Dehydroepiandrosterone Sulfate; Follow-Up Studies; Humans; Male; Middle Aged; Prognosis; Prostatic Neoplasms, Castration-Resistant; Retrospective Studies; Survival Rate | 2018 |
Association of prostate cancer SLCO gene expression with Gleason grade and alterations following androgen deprivation therapy.
Topics: Adult; Aged; Androgen Antagonists; Androstenes; Dehydroepiandrosterone Sulfate; Disease Progression; Docetaxel; Follow-Up Studies; Gene Expression Regulation, Neoplastic; Humans; Male; Middle Aged; Neoplasm Grading; Organic Anion Transporters; Prostate; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms, Castration-Resistant; Solute Carrier Organic Anion Transporter Family Member 1B3; Testosterone; Treatment Outcome | 2019 |